Singapore markets close in 6 hours 10 minutes
Straits Times Index
3,251.76 +12.73 (+0.39%) Nikkei
27,497.45 +20.58 (+0.07%) Hang Seng
19,687.53 +119.84 (+0.61%) FTSE 100
7,471.77 +66.32 (+0.90%) Bitcoin USD
27,008.02 -843.73 (-3.03%) CMC Crypto 200
589.59 -17.86 (-2.94%)
UroGen Pharma Ltd. (0XOD.L)
LSE - LSE Delayed Price. Currency in USD
Add to watchlist
At close: 07:29PM BST
| Previous close | 8.50 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.121M |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Axsome Therapeutics (AXSM) Reports Q4 Loss, Tops Revenue Estimates
Axsome (AXSM) delivered earnings and revenue surprises of -8.47% and 13.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of -19.40% and 6.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Prothena (PRTA) Reports Q1 Loss, Tops Revenue Estimates
Prothena (PRTA) delivered earnings and revenue surprises of 8.24% and 401.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
